Comparison of uniaxial compression test and simulation. by Ruocheng Zhang (20442445)

Subjects:

Temperature nephogram of the PDC cutter. by Ruocheng Zhang (20442445)

Subjects:

Relevant material parameters used in the finite element analysis. by Ruocheng Zhang (20442445)

Subjects:

Average cutting force and MSE at different vibration frequencies. by Ruocheng Zhang (20442445)

Subjects:

Comparison of rock stresses in the cutting process. by Ruocheng Zhang (20442445)

Subjects:

Cutting force variation under different UHFV loads. by Ruocheng Zhang (20442445)

Subjects:

Temperature variation curves of the PDC cutter under ultrasonic vibration at different frequencies. by Ruocheng Zhang (20442445)

Subjects:

Effects of chronic ISO infusion on cardiac function in Epac1TG. by Yoshiki Ohnuki (576298)

Subjects:

Epac activation increased MYPT phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

Subjects:

Oviduct Glycoprotein 1 (OVGP1) Diagnoses Polycystic Ovary Syndrome (PCOS) Based on Machine Learning Algorithms by Fengjuan Wang (768949)

Subjects:

The amplitude curve. by Ruocheng Zhang (20442445)

Subjects:

The stress-strain curve in rock failure process. by Ruocheng Zhang (20442445)

Subjects:

Finite element modeling of PDC cutter with rock. by Ruocheng Zhang (20442445)

Subjects:

Expression pattern of statistically significantly differentially expressed immune-related genes in CL patients compared to healthy volunteers. by Nasrin Masoudzadeh (20300511)

“…The red and blue colors of the bar plot represent relative significant increased or decreased expression of the genes in patients compared to healthy samples. …”

(a)(b)(c). Relationship between the OHAT-J score for “lips” or “saliva” or “dentures” and the BI at discharge. by Misaki Nakamura (756854)

Changes in connectivity of the mPFC among responders and non-responders. by Karel Joineau (21799908)

Subjects:

Data supporting this article. by Karel Joineau (21799908)

Subjects:

CONSORT diagram showing the flow of participants through each stage of the DOREPAR randomized trial for the main outcome (change of VAS). by Karel Joineau (21799908)

Subjects:

Demographic and clinical data at baseline. by Karel Joineau (21799908)

Subjects:

Changes in clinical variables. by Karel Joineau (21799908)

Subjects: